Sanofi and Boehringer Ingelheim seek CCI’s clearance for global asset swap deal worth $25 billion
Advertisement
Advertisement
Once completed, the $41 billion France-based
The companies filed their applications to CCI late last week, stating that their mutual transfers, of both the consumer healthcare business and the animal health business, will not considerably put an unfavourable effect on the competition that exists in any of the potential relevant markets in the country.
Now it’s up to the commission to review if this swapping will cause any undesirable impact on the competition in India, a market where both these companies have been progressively growing their businesses over the last few years.
Advertisement
Swapping of assets is a new trend that one can see in the global healthcare businesses. In 2014, the commission had cleared a three-way deal between Novartis, GlaxoSmithKline and Eli Lilly. The deal enabled Swiss-based Novartis to acquire the oncology assets of GSK, based in Britain; in return of this, GSK acquired its vaccines business. The deal also led to a JV for consumer healthcare products, and GSK selling its animal healthcare arm to Indiana, US-based Eli Lilly.
Image sources: 1 and 2
Advertisement
- IMD forcasts heatwave for few states in next 5 days
- IIFL Securities Q4 profit more than doubles to ₹180 crore
- Global economy to grow 2.7% in 2024 as major economies avoid severe downturn: UN report
- North Korea has fired a ballistic missile toward Sea of Japan, says South Korean military
- Finance minister asks for greater push and investment in the manufacturing sector at the CII Annual Summit
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market